Tạp Chí Nghiên Cứu Y Học · Aug 25, 2026
Effectiveness of the Vivifrail program on motor function and fall risk in older patients with type 2 diabetes and frailty syndrome
By Ngân DTK, Ngọc NH, Huyền VTT
A randomized controlled intervention study involving 72 patients with type 2 diabetes aged 60 years or older with frailty syndrome (HCDBTT). Patients were assigned to an intervention group (n = 36) participating in the Vivifrail program and a control group (n = 36) receiving usual care. Measures were assessed at baseline, after 3 months, and after 6 months, including motor function (Timed Up and Go, TUG) and fall risk scores (Fall Risk Index-21, FRI-21). A total of 66 patients completed the study after 6 months of follow-up. At baseline, there were no differences in demographic, diabetes-related, and geriatric characteristics between the two groups (p > 0.05). After 6 months of intervention, TUG completion time in the intervention group decreased by an average of 3.8 seconds from 15.6 ± 5.9 seconds to 11.8 ± 2.9 seconds, while that in the control group increased by 1.1 seconds from 15.3 ± 5.5 seconds to 16.4 ± 6.4 seconds. The FRI-21 score in the intervention group decreased by an average of 4.1 points from 11.4 ± 3.3 points to 7.3 ± 3.0 points, while the control group showed no change. Changes in TUG time and FRI-21 scores in the intervention group were better than those in the control group at 3 months and 6 months (p < 0.05). The Vivifrail program helps significantly improve motor function and reduce fall risk in older patients with type 2 diabetes and HCDBTT.